Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 391.05 INR 1.12% Market Closed
Market Cap: 48.2B INR
Have any thoughts about
Hikal Ltd?
Write Note

Hikal Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikal Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Total Equity
â‚ą11.9B
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Equity
â‚ą282.5B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Equity
â‚ą283.6B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Equity
â‚ą691.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Equity
â‚ą75B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
12%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Equity
â‚ą93.6B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hikal Ltd
Glance View

Market Cap
48.2B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
264.85 INR
Overvaluation 32%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Total Equity?
Total Equity
11.9B INR

Based on the financial report for Jun 30, 2024, Hikal Ltd's Total Equity amounts to 11.9B INR.

What is Hikal Ltd's Total Equity growth rate?
Total Equity CAGR 3Y
8%

Over the last year, the Total Equity growth was 5%. The average annual Total Equity growth rates for Hikal Ltd have been 8% over the past three years .

Back to Top